Henry Ji
Wapampando, Purezidenti ndi CEO
- Zaka 25+ akugwira ntchito mu biotechnology ndi sayansi ya moyo
- Dr. Ji anayambitsa Sorrento ndipo wakhala mtsogoleri kuyambira 2006, CEO ndi Purezidenti kuyambira 2012, ndi Chairman kuyambira 2017.
- Munthawi yake ku Sorrento, adapanga ndikuwongolera kukula kwa Sorrento kudzera pakugula ndi kuphatikiza kuphatikiza Bioserv, Scilex Pharmaceuticals, Concortis Biotherapeutics, Levena Biopharma, LACEL, TNK Therapeutics, Virttu Biologics, Ark Animal Health, ndi Sofurysa Systems Lymphatic.
- Anatumikira monga Chief Scientific Officer wa Sorrento kuyambira 2008 mpaka 2012 komanso ngati Mtsogoleri Wachigawo wapakati kuyambira 2011 mpaka 2012.
- Sorrento isanachitike, adakhala ndi maudindo akuluakulu ku CombiMatrix, Stratagene komanso adayambitsanso Stratagene Genomics, nthambi ya Stratagene, ndipo adakhala Purezidenti & CEO ndi Director wa Board.
- BS ndi Ph.D.
Tsekani >
Mike Royal
Chief Medical Officer
- Dr. Royal ndi mkulu wa mankhwala omwe ali ndi zaka 20 za chitukuko chachipatala ndi zochitika zachipatala. Posachedwapa, anali Chief Medical Officer wa Suzhou Connect Biopharmaceuticals ndipo, zisanachitike, Concentric Analgesics. Amalumikizananso ndi Sorrento komwe anali EVP, Clinical Development and Regulatory Affairs mu 2016.
- Adachitapo kanthu kapena adathandizira ma NDA angapo opambana, kuphatikiza ma NCE, 505(b) (2)s ndi ANDAs.
- Dr. Royal ndi gulu lovomerezeka mu mankhwala amkati, mankhwala opweteka, anesthesiology omwe ali ndi ziyeneretso zina zowonjezera ululu, mankhwala osokoneza bongo ndi mankhwala ovomerezeka.
- Wakhala Wothandizira Pulofesa wa Zamankhwala ku Uniformed Services University of Health Sciences, Pulofesa Wothandizira wa Anesthesiology / Critical Care Medicine ku yunivesite ya Pittsburgh Medical Center, ndi Pulofesa Wothandizira pa yunivesite ya Oklahoma ndi yunivesite ya California San Diego.
- Wasindikiza kwambiri ndi mitu yopitilira 190 yamabuku, zolemba zowunikidwa ndi anzawo ndi zolemba / zikwangwani; ndipo wakhala woyitanidwa wokamba nkhani pamisonkhano yadziko lonse ndi yapadziko lonse lapansi
- BS, MD, JD, MBA
Tsekani >
Elizabeth Czerepak
Wachiwiri kwa Purezidenti, Chief Financial Officer, Chief Business Officer
- Zaka 35+ zazachuma komanso zogwirira ntchito mu biotech ndi zamankhwala
- Mayi Czerepak anakhala zaka 18 ku Pharma yaikulu ndi zaka 11 monga CFO wa biotechs zosiyanasiyana, kumene anatsogolera ntchito zandalama, mgwirizano ndi M&A. Anayamba ntchito yake ku Merck & Co., adatenga gawo lalikulu pakugula kwa Roche $5.4B ya Syntex, ndipo adatsogolera zoyesayesa za Humira® zomwe zidapangitsa kugulitsa kwa BASF Pharma $6.8B kwa Abbott.
- Kwa zaka zisanu ndi zinayi monga Managing Director ku JP Morgan ndi Bear Stearns, adayambitsa mnzake wamkulu wa thumba la ndalama zokwana $212M, komwe adatsogolera mabizinesi 13 a biotechs, kutumikira pama board ndikuthandizira kutuluka kudzera ku IPO ndi kugula. Series 7 ndi Series 63 FINRA (NASD) Woyimira Wolembetsa kuyambira 2001 mpaka 2008.
- Membala wodziwa bwino za board (kuphatikiza Sorrento ndi Scilex) komanso wapampando wowerengera, akupeza Satifiketi Yoyang'anira Corporate kuchokera ku Harvard Business School mu 2020.
- BA ndi MBA
Tsekani >
Mark R. Brunswick
Senior Vice President Regulatory Affairs
- Dr. Brunswick ali ndi zaka zoposa 35 za maudindo akuluakulu mu Makampani Olamulidwa kuphatikizapo zaka 9 ku US FDA, Center for Biologics, Division of Monoclonal Antibodies.
- Asanalowe ku Sorrento, Dr. Brunswick anali Mtsogoleri wa Regulatory Affairs and Quality ku Sophiris Bio, kampani yomwe ikupanga mankhwala a benign prostatic hyperplasia ndi khansa ya prostate. Izi zisanachitike anali wamkulu wa Regulatory Affairs ku Arena Pharmaceuticals okhazikika pazamankhwala omwe amaperekedwa ku G Protein receptors.
- Dr. Brunswick adatsogolera gulu loyang'anira ku Elan Pharmaceuticals lomwe limayang'ana kwambiri matenda a Alzheimer's ndi pain compound, ziconotide.
- BS ndi Ph.D.
Tsekani >
Robert D. Allen
Wachiwiri kwa Purezidenti R&D
- Dr. Allen wakhala zaka zoposa 15 akugwira ntchito yofufuza zamoyo, chitukuko chachipatala, komanso kupanga mankhwala oletsa tizilombo toyambitsa matenda ndi khansa.
- Asanalowe ku Sorrento, Dr. Allen adagwira ntchito ngati Mtsogoleri wa Sayansi wa Oregon Translational Research and Development Institute (OTRADI), akuthandizana ndi makampani ndi akatswiri a maphunziro pakupeza mankhwala osokoneza bongo ndi kampeni yowonetsera anthu omwe akufunafuna khansa ya hematologic, zotupa zolimba, ndi tizilombo toyambitsa matenda.
- OTRADI isanachitike, Dr. Allen adapanga mapulogalamu otulukira ku SIGA Technologies omwe adazindikira ma antivayirasi omwe amayang'ana ma virus mu mabanja a bunyavirus ndi filovirus komanso njira zothana ndi ma virus ambiri amunthu ndikukakamiza mabakiteriya olowa m'thupi.
- BS ndi Ph.D.
Tsekani >
Xiao Xu
Purezidenti ACEA
- Dr. Xu ali ndi zaka zopitilira 20 ngati wamkulu pamafakitale aukadaulo waukadaulo. Dr. Xu anali cofounder, purezidenti ndi CEO wa ACEA Biosciences (yomwe inapezedwa ndi Agilent mu 2018) ndi ACEA Therapeutics (yopezedwa ndi Sorrento Therapeutics mu 2021). Amajowina Sorrento Therapeutics atalandira, ndipo akupitiriza kugwira ntchito ngati Purezidenti wa ACEA, wothandizira wa Sorrento Therapeutics.
- Iye wakhala akuyang'anira ndikuyang'anira chitukuko cha mapaipi amankhwala a ACEA, maphunziro azachipatala, ndi malo opanga cGMP.
- Iye ndi amene adayambitsa ukadaulo waukadaulo waukadaulo wopangidwa ndi ma cell komanso omwe ali ndi udindo paukadaulo/chitukuko chazinthu komanso mgwirizano wamabizinesi ndi Roche Diagnosis, kutsatsa kwapadziko lonse kwaukadaulo ndi zinthu za ACEA, ndikupeza $250 miliyoni Agilent ya ACEA Biosciences.
- Wakhala wofufuza ndi wasayansi wofufuza ku Gladstone Institutes, The Scripps Research Institute ndi US Centers for Disease Control and Prevention. Ali ndi ma patent opitilira 50 aku US komanso mapulogalamu a patent ndipo wasindikiza zolemba zopitilira 60 m'magazini apadziko lonse lapansi, kuphatikiza Science, PNAS, Nature Biotechnology, ndi Chemistry ndi Biology.
- BS, MS, ndi MD
Tsekani >
Shawn Sahebi
Wachiwiri kwa Purezidenti Wantchito Zamalonda
- Dr. Sahebi amatsogolera ntchito zamalonda za Sorrento
- Zimabweretsa zaka zopitilira 30 zazamankhwala kuphatikiza sayansi yamalonda ndi njira zamalonda ku Sorrento
- Asanalowe ku Sorrento, adakhala ndi maudindo akuluakulu ndi Novartis, Pfizer, ndi Lilly omwe akupanga kusanthula kwamalonda ndi njira zotsatsira zomwe zimatengera kukula kwa malonda azinthu zopitilira 20 zomwe zidafika pachimake m'malo a Cardiovascular, Arthritis, Neuroscience, Diabetes, and Oncology.
- Wokhulupirira mwamphamvu kuti zikhalidwe zogwirizanitsa zimapanga magulu opambana
- Purezidenti wakale, Pharmaceutical Management Science Association of America
- BA, MBA ndi Ph.D.
Tsekani >
Brian Cooley
Wachiwiri kwa Purezidenti, Corporate Communications ndi Lymphatic Drug Development BU
- Zaka 30+ zokumana nazo mumakampani a biopharmaceutical ndi sayansi ya moyo
- Bambo Cooley anali ndi maudindo osiyanasiyana ogulitsa, malonda, ndi utsogoleri wamalonda m'makampani olemera 500 ndipo atsogolereratu kusonkhanitsa ndalama ndikuyambitsa ntchito zamakampani azachipatala.
- Asanalowe ku Sorrento, Bambo Cooley adatsogolera ntchito zatsopano zotsatsa malonda padziko lonse lapansi ndi udindo wa P&L ku Eli Lilly ndi Company ndi Genentech m'malo a matenda monga Diabetes, Neurology, Immunology and Rare Disease.
- Kuphatikiza apo, adatsogoleranso ntchito zazikulu za BD, zopatsa chilolezo, komanso zophatikizira padziko lonse lapansi komanso ku US. Izi zidaphatikizanso mabizinesi angapo aku Europe, Middle East ndi Africa, komanso mgwirizano wa $ 400MM kuti apereke chilolezo, kukulitsa ndi kugulitsa. woyamba GLP-1 agonist
- Posachedwapa, Bambo Cooley anali CBO ku Sofusa Business Unit ku Kimberly-Clark ndipo anatsogolera ntchito yogulitsa bwino ndi kuphatikiza. Sorrento Therapeutics. Akupitiriza kutsogolera gawo la Lymphatic Drug Delivery systems ku Sorrento.
- BS
Tsekani >
Bill Farley
Wachiwiri kwa Purezidenti Business Development
- Zaka 30+ zakuchitikira mu Business Development, Zogulitsa ndi kuyesetsa kutsogolera pakupeza mankhwala, chitukuko ndi mgwirizano
- Asanalowe ku Sorrento, Bambo Farley adakhala ndi maudindo a utsogoleri ku HitGen, WuXi Apptec, VP ya zomangamanga za Key Accounts ndikutsogolera gulu la BD padziko lonse; ChemDiv, Wachiwiri kwa Wachiwiri kwa BD ku, akutsogolera zoyesayesa zingapo zopanga makampani azachipatala atsopano mu CNS, Oncology ndi Anti-infectives.
- Bambo Farley adatumikirapo ngati mlangizi ku magulu osiyanasiyana oyang'anira akuluakulu ndi ma BOD kuti apange ndi kugulitsa katundu ndi Xencor, Caliper Technologies ndi Stratagene.
- Wapanga maukonde olimba m'makampani opanga mankhwala, biotech ndi gulu la Venture Capital. Bambo Farley adalankhula pamisonkhano yambiri ndipo adasindikizidwa m'magazini osiyanasiyana omwe amawunikiridwa ndi anzawo
- BS
Tsekani >
Alexis Nahama
Wachiwiri kwa Purezidenti Neurotherapeutics BU
- Dr. Nahama amatsogolera mapulogalamu a RTX okhudza thanzi la anthu ndi nyama
- Monga gulu la utsogoleri, Dr. Nahama amathandizira kukonza njira, amayang'anira ntchito zamtengo wapatali, amathandizira kukonzekera msika, ndikulimbikitsa mgwirizano wakunja.
- Mwachidwi amayendetsa mwayi womasulira kuti apititse patsogolo mapulogalamu a chitukuko cha anthu ndikubweretsa ukadaulo womwe sukanakhalapo kwa ziweto.
- Asanalowe ku Sorrento, adakhala zaka zopitilira 25 akugwira ntchito mu Life Sciences ndi Biotechnology ku Sanofi, Colgate, Novartis, Merck, VCA Antech ndi VetStem Biopharma.
- DVM yokhala ndi ntchito yoyambirira yoyang'ana pa R&D pamalo opweteka (mayesero azachipatala a ziweto)
Tsekani >